Food and Drug Administration

Joint meeting of the

Transmissible Spongiform Encephalopathies Advisory Committee
and the
Blood Products Advisory Committee

January 17, 2002

Briefing Information

Topic 1. Effectiveness of measures taken to protect humans from food-borne exposure to the agent of bovine spongiform encephalopathy (BSE):  Implications for risk of variant Creutzfeldt-Jakob Disease (vCJD) and blood safety - Issue Statement   pdf   htm   doc

Additional information on topics for the Joint Meeting of the TSE Advisory Committee and Blood Products Advisory Committee    pdf   htm   doc

Guidance for Industry: Revised Precautionary Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and New Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products, January 2002   pdf   htm